HIV TREATMENT
2020
Pharmaceutical companies, SRAs, WHO Prequalification Programme (PQ) and NRAs commit to:
Action 27. Mobilize their networks and work with communities to help build treatment literacy, generate demand, and expand access to ARVs among children.
Action 34. Increase efforts to share information on the roll-out of new paediatric formulations, including lessons learned.
Paediatric HIV & TB : Rome Action Plan
Action 39
GAP-f partners develop a work plan for finalization, roll-out and increasing demand for and accelerating access to 2-3 high priority drugs planned for approval in 2018.
Committed by:
Co-Chairs of the AIDS Free Working Group of the Start Free, Stay Free, AIDS Free framework
Sub-Actions & Milestones
Sub-action 39.1
GAP-f partners develop a work plan for finalization, roll-out and increasing demand for and accelerating access to 2-3 high priority drugs planned for approval in 2018.
AIDS Free Co-Chairs
Concept note was revised, Lancet and IAS papers released, presentation of the principles behind the business plan at AIDS2018, business plan being finalized for presentation to key stakeholders by Rome 4
-
Document (s)
-
-
-
-
Updates
Notes
Responsible